🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, placebo-controlled, double-blind, 3-way crossover pha...
Status
Completed
Location
Research Site
Start Date
2017-09-06
Trial ID
NCT03258515
Treatments Being Tested
This study will determine the cardiovascular effects of energy drink consum...
Status
Terminated
Location
David Grant Medical Center
Start Date
2017-06-26
Trial ID
NCT03021616
Treatments Being Tested
48 healthy adult male \& female subjects will be enrolled in this study to ...
Status
Completed
Location
Charles River Clinical Services Northwest
Start Date
2008-04
Trial ID
NCT00721344
A randomised, placebo controlled thorough QTc study to evaluate the effect ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-23
Trial ID
NCT01209026
The purpose of this study is to assess the effect of canagliflozin (JNJ-284...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT01787357
Treatments Being Tested
The purpose of the study is to investigate the effects of multiple oral dos...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2023-05-15
Trial ID
NCT05878522
Treatments Being Tested
This is a Thorough QT study intended to estimate the effect of glasdegib at...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2017-06-09
Trial ID
NCT03162900
The purpose of this study is to evaluate the potential effect of naltrexone...
Status
Completed
Location
Multiple Locations
Start Date
2016-04
Trial ID
NCT02735603
Treatments Being Tested
The purpose of this study is to investigate the safety, tolerability, and p...
Status
Completed
Location
Celerion
Start Date
2025-02-27
Trial ID
NCT06846866
Treatments Being Tested
This is a double-blind (vis-a-vis lenvatinib), randomized, placebo-controll...
Status
Completed
Location
Charles River
Start Date
2010-12
Trial ID
NCT01525394
Treatments Being Tested